The University of Southampton
University of Southampton Institutional Repository

Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT

Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT
Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT

Background: most patients with oesophageal cancer present with incurable disease. For those with advanced disease, the mean survival is 3–5 months. Treatment emphasis is therefore on effective palliation, with the majority of patients requiring intervention for dysphagia. Insertion of a self-expanding metal stent provides rapid relief but dysphagia may recur within 3 months owing to tumour progression. Evidence reviews have called for trials of interventions combined with stenting to better maintain the ability to swallow. 

Objectives: the Radiotherapy after Oesophageal Cancer Stenting (ROCS) study examined the effectiveness of palliative radiotherapy, combined with insertion of a stent, in maintaining the ability to swallow. The trial also examined the impact that the ability to swallow had on quality of life, bleeding events, survival and cost-effectiveness. 

Design: a pragmatic, multicentre, randomised controlled trial with follow-up every 4 weeks for 12 months. An embedded qualitative study examined trial experiences in a participant subgroup. Setting: Participants were recruited in secondary care, with all planned follow-up at home. Participants: Patients who were referred for stent insertion as the primary management of dysphagia related to incurable oesophageal cancer. Interventions: Following stent insertion, the external beam radiotherapy arm received palliative oesophageal radiotherapy at a dose of 20 Gy in five fractions or 30 Gy in 10 fractions. 

Main outcome measures: the primary outcome was the difference in the proportion of participants with recurrent dysphagia, or death, at 12 weeks. Recurrent dysphagia was defined as deterioration of ≥ 11 points on the dysphagia scale of the European Organisation of Research and Treatment of Cancer Quality of Life Questionnaire oesophago-gastric module questionnaire. Secondary outcomes included quality of life, bleeding risk and survival. 

Results: the study recruited 220 patients: 112 were randomised to the usual-care arm and 108 were randomised to the external beam radiotherapy arm. There was no evidence that radiotherapy reduced recurrence of dysphagia at 12 weeks (48.6% in the usual-care arm compared with 45.3% in the external beam radiotherapy arm; adjusted odds ratio 0.82, 95% confidence interval 0.40 to 1.68; p = 0.587) and it was less cost-effective than stent insertion alone. There was no difference in median survival or key quality-of-life outcomes. There were fewer bleeding events in the external beam radiotherapy arm. Exploration of patient experience prompted changes to trial processes. Participants in both trial arms experienced difficulty in managing the physical and psychosocial aspects of eating restriction and uncertainties of living with advanced oesophageal cancer. 

Limitations: change in timing of the primary outcome to 12 weeks may affect the ability to detect a true intervention effect. However, consistency of results across sensitivity analyses is robust, including secondary analysis of dysphagia deterioration-free survival. 

Conclusions: widely accessible palliative external beam radiotherapy in combination with stent insertion does not reduce the risk of dysphagia recurrence at 12 weeks, does not have an impact on survival and is less cost-effective than inserting a stent alone. Reductions in bleeding events should be considered in the context of patient-described trade-offs of fatigue and burdens of attending hospital. Trial design elements including at-home data capture, regular multicentre nurse meetings and qualitative enquiry improved recruitment/data capture, and should be considered for future studies. Future work: Further studies are required to identify interventions that improve stent efficacy and to address the multidimensional challenges of eating and nutrition in this patient population. Trial registration: Current Controlled Trials ISRCTN12376468 and Clinicaltrials.gov NCT01915693.

Cost-Benefit Analysis, Deglutition Disorders/etiology, Esophageal Neoplasms/complications, Humans, Neoplasm Recurrence, Local/radiotherapy, Quality of Life, Stents
1366-5278
Adamson, Douglas
d405637d-a330-4c0b-b7fa-317dc7c4c479
Blazeby, Jane
689d490e-fca3-4430-88de-f19ec6cebf58
Porter, Catharine
8e89ea8c-0b11-4945-8053-21094cffb231
Hurt, Christopher
bf8b37a0-8f08-4b47-b3f3-6fc65f7ab87f
Griffiths, Gareth
7fd300c0-d279-4ff6-842d-aa1f2b9b864d
Nelson, Annmarie
9be17968-fda0-4bd8-94cd-96d772f5083c
Sewell, Bernadette
d753e76b-592d-4abe-a4f3-c0f8aa8b41ce
Jones, Mari
312603c6-dab1-4265-b1ac-5295ff6806f0
Svobodova, Martina
cc15aad8-c657-4285-94e7-bd64985769a1
Fitzsimmons, Deborah
4e282651-162f-48f0-bbf7-190c265279f2
Nixon, Lisette
e99b2dce-91a5-4267-940b-92ae83f8a9aa
Fitzgibbon, Jim
2fea06df-ef50-4f5f-bf03-f774d6179943
Thomas, Stephen
75f054dd-2989-47b9-8107-6bc1868f8ac0
Millin, Anthony
1040afe4-5984-42af-8fae-4868686f1217
Crosby, Tom
d641cb6d-efc6-45ae-b083-a21c599a032c
Staffurth, John
51734078-ea1f-4188-8d32-75f786921586
Byrne, Anthony
3923c5bf-7ce9-42a3-bd67-383032b48986
et al.
Adamson, Douglas
d405637d-a330-4c0b-b7fa-317dc7c4c479
Blazeby, Jane
689d490e-fca3-4430-88de-f19ec6cebf58
Porter, Catharine
8e89ea8c-0b11-4945-8053-21094cffb231
Hurt, Christopher
bf8b37a0-8f08-4b47-b3f3-6fc65f7ab87f
Griffiths, Gareth
7fd300c0-d279-4ff6-842d-aa1f2b9b864d
Nelson, Annmarie
9be17968-fda0-4bd8-94cd-96d772f5083c
Sewell, Bernadette
d753e76b-592d-4abe-a4f3-c0f8aa8b41ce
Jones, Mari
312603c6-dab1-4265-b1ac-5295ff6806f0
Svobodova, Martina
cc15aad8-c657-4285-94e7-bd64985769a1
Fitzsimmons, Deborah
4e282651-162f-48f0-bbf7-190c265279f2
Nixon, Lisette
e99b2dce-91a5-4267-940b-92ae83f8a9aa
Fitzgibbon, Jim
2fea06df-ef50-4f5f-bf03-f774d6179943
Thomas, Stephen
75f054dd-2989-47b9-8107-6bc1868f8ac0
Millin, Anthony
1040afe4-5984-42af-8fae-4868686f1217
Crosby, Tom
d641cb6d-efc6-45ae-b083-a21c599a032c
Staffurth, John
51734078-ea1f-4188-8d32-75f786921586
Byrne, Anthony
3923c5bf-7ce9-42a3-bd67-383032b48986

Adamson, Douglas, Blazeby, Jane and Porter, Catharine , et al. (2021) Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT. Health technology assessment (Winchester, England), 25 (31). (doi:10.3310/hta25310).

Record type: Article

Abstract

Background: most patients with oesophageal cancer present with incurable disease. For those with advanced disease, the mean survival is 3–5 months. Treatment emphasis is therefore on effective palliation, with the majority of patients requiring intervention for dysphagia. Insertion of a self-expanding metal stent provides rapid relief but dysphagia may recur within 3 months owing to tumour progression. Evidence reviews have called for trials of interventions combined with stenting to better maintain the ability to swallow. 

Objectives: the Radiotherapy after Oesophageal Cancer Stenting (ROCS) study examined the effectiveness of palliative radiotherapy, combined with insertion of a stent, in maintaining the ability to swallow. The trial also examined the impact that the ability to swallow had on quality of life, bleeding events, survival and cost-effectiveness. 

Design: a pragmatic, multicentre, randomised controlled trial with follow-up every 4 weeks for 12 months. An embedded qualitative study examined trial experiences in a participant subgroup. Setting: Participants were recruited in secondary care, with all planned follow-up at home. Participants: Patients who were referred for stent insertion as the primary management of dysphagia related to incurable oesophageal cancer. Interventions: Following stent insertion, the external beam radiotherapy arm received palliative oesophageal radiotherapy at a dose of 20 Gy in five fractions or 30 Gy in 10 fractions. 

Main outcome measures: the primary outcome was the difference in the proportion of participants with recurrent dysphagia, or death, at 12 weeks. Recurrent dysphagia was defined as deterioration of ≥ 11 points on the dysphagia scale of the European Organisation of Research and Treatment of Cancer Quality of Life Questionnaire oesophago-gastric module questionnaire. Secondary outcomes included quality of life, bleeding risk and survival. 

Results: the study recruited 220 patients: 112 were randomised to the usual-care arm and 108 were randomised to the external beam radiotherapy arm. There was no evidence that radiotherapy reduced recurrence of dysphagia at 12 weeks (48.6% in the usual-care arm compared with 45.3% in the external beam radiotherapy arm; adjusted odds ratio 0.82, 95% confidence interval 0.40 to 1.68; p = 0.587) and it was less cost-effective than stent insertion alone. There was no difference in median survival or key quality-of-life outcomes. There were fewer bleeding events in the external beam radiotherapy arm. Exploration of patient experience prompted changes to trial processes. Participants in both trial arms experienced difficulty in managing the physical and psychosocial aspects of eating restriction and uncertainties of living with advanced oesophageal cancer. 

Limitations: change in timing of the primary outcome to 12 weeks may affect the ability to detect a true intervention effect. However, consistency of results across sensitivity analyses is robust, including secondary analysis of dysphagia deterioration-free survival. 

Conclusions: widely accessible palliative external beam radiotherapy in combination with stent insertion does not reduce the risk of dysphagia recurrence at 12 weeks, does not have an impact on survival and is less cost-effective than inserting a stent alone. Reductions in bleeding events should be considered in the context of patient-described trade-offs of fatigue and burdens of attending hospital. Trial design elements including at-home data capture, regular multicentre nurse meetings and qualitative enquiry improved recruitment/data capture, and should be considered for future studies. Future work: Further studies are required to identify interventions that improve stent efficacy and to address the multidimensional challenges of eating and nutrition in this patient population. Trial registration: Current Controlled Trials ISRCTN12376468 and Clinicaltrials.gov NCT01915693.

Text
3036701 - Version of Record
Available under License Creative Commons Attribution.
Download (2MB)

More information

e-pub ahead of print date: 25 May 2021
Published date: 25 May 2021
Keywords: Cost-Benefit Analysis, Deglutition Disorders/etiology, Esophageal Neoplasms/complications, Humans, Neoplasm Recurrence, Local/radiotherapy, Quality of Life, Stents

Identifiers

Local EPrints ID: 453357
URI: http://eprints.soton.ac.uk/id/eprint/453357
ISSN: 1366-5278
PURE UUID: f2d0d862-c2ac-4510-9d58-0f745b6cd756
ORCID for Christopher Hurt: ORCID iD orcid.org/0000-0003-1206-8355
ORCID for Gareth Griffiths: ORCID iD orcid.org/0000-0002-9579-8021

Catalogue record

Date deposited: 13 Jan 2022 18:13
Last modified: 21 Mar 2024 03:14

Export record

Altmetrics

Contributors

Author: Douglas Adamson
Author: Jane Blazeby
Author: Catharine Porter
Author: Christopher Hurt ORCID iD
Author: Annmarie Nelson
Author: Bernadette Sewell
Author: Mari Jones
Author: Martina Svobodova
Author: Deborah Fitzsimmons
Author: Lisette Nixon
Author: Jim Fitzgibbon
Author: Stephen Thomas
Author: Anthony Millin
Author: Tom Crosby
Author: John Staffurth
Author: Anthony Byrne
Corporate Author: et al.

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×